Evaluation of subcutaneous injection pain with C.E.R.A. and darbepoetin alfa in CAPD patients

Therapeutic Research

Volumn 33, Issue 3, 2012, Pages 413-419

  Oka, Masatoshi ^a   Mochizuki, Takahiro ^a   Kamiyama, Michiaki ^a   Suzuki, Miki ^a   Akiyama, Kenichi ^a   Watanabe, Yoshihiko ^a   Ohara, Mamiko ^a  

^a KAMEDA MEDICAL CENTER   (Japan)

Author keywords

C.E.R.A.

Indexed keywords

CONTINUOUS ERYTHROPOIESIS RECEPTOR ACTIVATOR; HEMOGLOBIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;

ARTICLE; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DRUG INJECTION VOLUME; HEMOGLOBIN BLOOD LEVEL; HUMAN; INJECTION PAIN; PAIN ASSESSMENT; RATING SCALE; STATISTICAL SIGNIFICANCE; VISUAL ANALOG SCALE;

EID: 84859643152     PISSN: 02898020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. ter Wee PM, de Koter Y, van der Veer O, van Vilet MH. Immediate pain sensation is less with subcutaneous epoetin- β compared to subcutaneous darbepoietin- α. Clin Nephrol 2009;72:177-80.
2. Wong D, Baker C. Reference manual for the Wong-Baker FACES pain rating scale. Whaley and Wong's Essentials of Pediatric Nursing. 5th ed. Missouri : Mosby-Year Book Inc:1997. p.1215-6.
3. Pannier A, Jordan P, Dougherty F C, Bour F, Reigner B. Subcutaneous injection pain with C.E.R.A., a continupus erythropoietin receptor activator, compared with darbepoetin alfa. Curr Med Res Opin 2007;23:3025-32.